R. Striberni

Effect of oxidative polymorphism (debrisoquine/sparteine type) on hepatic first-pass metabolism of bufuralol

L. Balant, T. Leemann, P. Dayer, 2004, European Journal of Clinical Pharmacology.

Dextromethorphan O‐demethylation in liver microsomes as a prototype reaction to monitor cytochrome P‐450 db1 activity

P. Dayer, P Dayer, T Leemann, 1989, Clinical pharmacology and therapeutics.

Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI).

T. Leemann, P. Dayer, J. Desmeules, 1988, Biochemical and biophysical research communications.

Differential consequences of renal failure on the pharmacokinetics of Oxprenolol and its main metabolite

L. Balant, P. Dayer, J. Fabre, 1983, European Journal of Drug Metabolism and Pharmacokinetics.